{
    "organizations": [],
    "uuid": "c3b09f13ec4746d6f5c2fd7d78d2969b59453cf6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-stellar-biotechnologies-reports-q1/brief-stellar-biotechnologies-reports-q1-loss-per-share-0-13-idUSASB0C4KZ",
    "ord_in_thread": 0,
    "title": "BRIEF-Stellar Biotechnologies Reports Q1 Loss Per Share $0.13",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 7, 2018 / 11:18 PM / in 26 minutes BRIEF-Stellar Biotechnologies Reports Q1 Loss Per Share $0.13 Reuters Staff \nFeb 7 (Reuters) - Stellar Biotechnologies Inc: \n* STELLAR BIOTECHNOLOGIES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS * Q1 LOSS PER SHARE $0.13 \n* ‍TOTAL REVENUES FOR QUARTER ENDED DECEMBER 31, 2017 WERE $.02 MILLION COMPARED TO $.14 MILLION FOR SAME PERIOD IN 2016​ Source text for Eikon: Further company coverage:",
    "published": "2018-02-08T07:18:00.000+02:00",
    "crawled": "2018-02-08T01:32:49.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "minute",
        "biotechnology",
        "report",
        "q1",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "stellar",
        "biotechnology",
        "inc",
        "stellar",
        "biotechnology",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "q1",
        "loss",
        "per",
        "share",
        "revenue",
        "quarter",
        "ended",
        "december",
        "million",
        "compared",
        "million",
        "period",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}